Shane Ward's Net Worth

$4.25 Million

Estimate Recalculated Sep 13, 2024 10:29PM EST

Who is Shane Ward

Shane Ward has an estimated net worth of $4.25 Million. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., BELLICUM PHARMACEUTICALS, INC, and Versartis, Inc..

SEC CIK

Shane Ward's CIK is 0001638380

Past Insider Trading and Trends

2017 was Shane Ward's most active year for acquiring shares with 5 total transactions. Shane Ward's most active month to acquire stocks was the month of February. 2017 was Shane Ward's most active year for disposing of shares, totalling 4 transactions. Shane Ward's most active month to dispose stocks was the month of February. 2019 saw Shane Ward paying a total of $9,821.60 for 98,000 shares, this is the most they've acquired in one year. In 2017 Shane Ward cashed out on 4,291 shares for a total of $61,191.17, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cidara Therapeutics, Inc.

COO & CLO
Updated Mar 20, 2024
Form 4
186.14%
370.00K
Mar 20, 2024
568.77K
Grant
Mar 15
Form 4
-9.34%
-20.47K
$0.67
-$13.71K
Mar 12, 2024
198.77K
Sale
Mar 11
Form 4
449.30%
380.00K
Mar 29, 2023
464.58K
Grant
Mar 27
Form 4
-4.87%
-4.33K
$1.53
-$6.62K
Mar 13, 2023
84.58K
Sale
Mar 13
Form 4
150.91K
$0.83
-$19.19K
Apr 04, 2022
150.91K
Grant
Mar 31
Form 4
250.00K
Aug 27, 2021
250.00K
Grant
Aug 25
Form 3
Aug 27, 2021
Showing 7 results

BELLICUM PHARMACEUTICALS, INC

Sr VP and Chief Legal SO
Updated Jun 02, 2020
Form 4
-5.39%
-107.00
$7.63
-$816.41
Jun 02, 2020
1.88K
Tax
May 29
Form 4
21.86K
Apr 09, 2020
21.86K
Grant
Apr 08
Form 4
410.00K
Feb 04, 2020
410.00K
Grant
Feb 03
Form 4
77.72%
8.00K
$1.23
$9.82K
Aug 30, 2019
18.29K
Purchase
Aug 29
Form 4
45.00K
Jun 11, 2019
45.00K
Grant
Jun 11
Form 4
-10.65%
-1.06K
$2.09
-$2.23K
May 30, 2019
8.94K
Tax
May 29
Form 4
45.00K
Feb 05, 2019
45.00K
Grant
Feb 01
Form 4
130.00K
May 29, 2018
130.00K
Grant
May 29
Form 3
May 29, 2018
Showing 9 results

Versartis, Inc.

SVP and General Counsel
Updated Feb 12, 2018
Form 4
-2.00%
-4.12K
$1.80
-$7.41K
Feb 12, 2018
201.56K
Sale
Feb 08
Form 4
82.70%
93.10K
Dec 22, 2017
205.67K
Grant
Dec 20
Form 4
21.60%
20.00K
Nov 29, 2017
112.57K
Grant
Nov 28
Form 4
-0.83%
-776.00
$2.55
-$1.98K
Oct 23, 2017
92.57K
Sale
Oct 19
Form 4
156.81%
57.00K
Oct 10, 2017
93.35K
Grant
Oct 06
Form 4
-5.32%
-2.04K
$19.01
-$38.79K
Mar 15, 2017
36.35K
Sale
Mar 14 - Mar 15
Form 4
339.09%
65.33K
$13.85
-$20.42K
Jan 31, 2017
84.59K
Grant
Jan 27 - Jan 30
Form 4
35.05%
5.00K
Oct 13, 2016
19.27K
Grant
Oct 11
Form 4
4,347.83%
55.00K
Feb 01, 2016
56.27K
Grant
Jan 28
Form 4
50.00K
Apr 08, 2015
50.00K
Grant
Apr 06
Form 3
Apr 08, 2015
Showing 11 results